El Hospital Italiano de Buenos Aires es una asociación civil sin fines de lucro dedicada a la medicina general y de alta complejidad. Fue fundado en 1853 por la Sociedad Italiana de Beneficencia en Buenos Aires,

During the past decade, Hospital Italiano de Buenos Aires conducted 147 clinical trials. In the 10-year time frame, 147 clinical trials started and 56 clinical trials were completed, i.e. on average, 38.1% percent of trials that started reached the finish line to date. In the past 5 years, 80 clinical trials started and 33 clinical trials were completed. i.e. 41.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Italiano de Buenos Aires" #1 sponsor was "Hospital Italiano de Buenos Aires" with 67 trials, followed by "Janssen Research & Development, LLC" with 16 trials sponsored, "Hoffmann-La Roche" with 13 trials sponsored, "Boehringer Ingelheim" with 10 trials sponsored and "Pfizer" with 10 trials sponsored. Other sponsors include 121 different institutions and companies that sponsored additional 87 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Italiano de Buenos Aires" #1 collaborator was "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Medical Research Council" with 3 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 3 trials as a collaborator and "AbbVie" with 2 trials as a collaborator. Other collaborators include 83 different institutions and companies that were collaborators in the rest 84 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Italiano de Buenos Aires" are "Alzheimer Disease" (6 trials), "HIV Infections" (6 trials), "Pulmonary Arterial Hypertension" (6 trials), "Hypertension" (5 trials) and "COPD" (4 trials). Many other conditions were trialed in "Hospital Italiano de Buenos Aires" in a lesser frequency.

Most popular intervention types in "Hospital Italiano de Buenos Aires" are "Drug" (140 trials), "Other" (25 trials), "Device" (16 trials), "Biological" (15 trials) and "Procedure" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (56 trials), "Cisplatin" (4 trials), "Dexamethasone" (4 trials), "Gantenerumab" (4 trials) and "placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Italiano de Buenos Aires" are 221 trials for "All" genders, 10 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 70 active trials in "Hospital Italiano de Buenos Aires". 1 are not yet recruiting, 47 are recruiting, 19 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 121 completed trials in Hospital Italiano de Buenos Aires, 1 suspended trials, and 23 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Italiano de Buenos Aires, 4 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 101 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 18 trials, and there were also 24 trials that are defined as “Not Applicable".

Hospital Italiano de Buenos Aires has several departments that took part in Clinical trials: "Hospital Italiano de Buenos Aires, Department of Pediatrics" - 2 trials, "Hospital Italiano de Buenos Aires; Rheumatology department" - 2 trials, "Hosital Italiano de Buenos Aires - Cardiologia" - 2 trials, "Hospital Italiano de Buenos Aires - Infectious Diseases Section" - 2 trials